Get in touch

Email: info@knownwell.health
Phone: 339-793-8998

Weight-Loss
Medication Pricing Guide

Last Updated: November 20, 2025
Disclaimer: knownwell does not dispense medications and is not a pharmacy. We do not set or control medication prices, and we do not receive any financial benefit based on which medication you choose, or whether you choose to use medication at all. Our role is to provide evidence-based medical guidance and help you access the safest, most effective treatment options for your care.

This page provides a centralized overview of obesity medication cash-pay drug pricing, based on information provided by the relevant drug manufacturer, to help you navigate treatment options, compare therapies, and stay informed throughout your care journey.

Overview of Obesity Management Medications

Obesity management medications fall into a few major categories based on how they work, how they’re taken, how strong their effects are, and who they’re best suited for. All options require a prescription and should be chosen with guidance from your clinician based on a variety of factors that might include: medical history, goals, cost, and tolerance. Below is an overview of obesity management medications:
Medication Class Brands Route Typical Weight Loss Notes
GLP-1 Wegovy®, Ozempic® Weekly injection 15–20%1 Strong clinical evidence of effectiveness1
GLP-1/GIP Zepbound® Weekly injection 15–23%2 Highest average weight loss currently available2x
Oral combo Qsymia® Daily pill 8–10%3 Can be a good alternative to injectables
Oral combo Contrave® Twice daily pill 5–8%4 Can be effective for craving-based eating patterns
1 STEP-1 trial found adult patients taking 2.4 mg semaglutide weekly achieved average weight loss of 15% after 68 weeks. Additionally, about 1 in 3 patients achieved 20% or more weight loss.

SURMOUNT-1 study found adult patients taking 5mg of tirzepatide achieved average weight reductions of 15.4%; adult patients taking 10mg of tirzepatide achieved average weight reductions of 19.9%; and adult patients taking 15 mg of tirzepatide achieved average weight reductions of 22.9%, compared to placebo (2.1%) at week 72.

3CONQUER trial found adult patients taking 7.5/46 mg of Qsymia® lost an average of ~7.8% of body weight; adult patients taking 15/92 mg of Qsymia® lost ~9.8%, compared with ~1.2% for placebo at 56 weeks.

 4 COR-BMOD study found adult patients taking Contrave® lost 8.1% (18 lbs) of their starting body weight vs 4.9% (11 lbs) with diet and exercise alone. COR-I Study found adult patients taking Contrave® lost 5.4% (12 lbs) of their starting body weight vs 1.3%
(3 lbs) with diet and exercise alone.

The following medications require a prescription. If you’d like to explore weight-loss medication options, please schedule a visit with a knownwell clinician today.

GLP-1: Wegovy® Self Pay (semaglutide)

The Wegovy® prices listed here reflect NovoCare® self-pay programs.
Total strength per volume Price for 1 month
(1 box)
Price for 2 months
(2 boxes)
Price for 3 months
(3 boxes)
Wegovy® 0.25 mg/0.5 mL injection Limited Time Offer for new patients: $199 for 2 months
$349
$398 for new patients
(until March 2026)
$698 regular
$1,047
Wegovy® 0.5 mg/0.5 mL injection Limited Time Offer for new patients: $199 for 2 months
$349
$698 $1,047
Wegovy® 1 mg/0.5 mL injection $349 $698 $1,047
Wegovy® 1.7 mg/0.75 mL injection $349 $698 $1,047
Wegovy® 2.4 mg/0.75 mL injection
(maintenance dose)
$349 $698 $1,047
All pricing is list pricing based on information provided by the respective drug manufacturers.  End user pricing may vary and for more details, consult with the drug manufacturers directly.

Wegovy® Helped Patients Lose 15% of Body Weight—1 in 3 Lost 20%+

In the STEP-1 trial, a large, double-blind study of adults with overweight or obesity, patients taking semaglutide 2.4 mg weekly lost an average of 15% of their body weight after 68 weeks. Additionally, about 1 in 3 patients achieved 20% or more weight loss.
Read more about Wegovy®

GLP-1: Ozempic® Self Pay (semaglutide) 

While Ozempic® is not formally approved for weight-management, clinicians sometimes prescribe it off-label for weight loss when it is a safe and appropriate option for a patient. Ozempic® is included in this pricing guide because, for some patients, it can be a more affordable way to access semaglutide.

The Ozempic® prices listed here reflect NovoCare® self-pay programs.
Total strength per volume Price for 1 month
(1 box)
Price for 2 months
(2 boxes)
Price for 3 months
(3 boxes)
Ozempic® 2 mg/3 mL injection Limited Time Offer for new patients: $199 for 2 months
$349
$698 $1,047
Ozempic® 4 mg/3 mL injection
$349 $698 $1,047
Ozempic® 8 mg/3 mL injection $499 $998 $1,497
All pricing is list pricing based on information provided by the respective drug manufacturers.  End user pricing may vary and for more details, consult with the drug manufacturers directly.

Ozempic® Helped Patients Lose 15% of Body Weight—1 in 3 Lost 20%+

In the STEP-1 trial, a large, double-blind study of adults with overweight or obesity, patients taking semaglutide 2.4 mg weekly lost an average of 15% of their body weight after 68 weeks. Additionally, about 1 in 3 patients achieved 20% or more weight loss.
Read more about Ozempic®

GLP-1: Zepbound® Self Pay (tirzepatide)

Route Total strength per volume Price for 1 month
(1 box / 4 doses)
Pen
(autoinjector)
Zepbound® 2.5 mg / 0.5 mL $650 with a coupon
Zepbound® 5 mg / 0.5 mL $650 with a coupon
Zepbound® 7.5 mg / 0.5 mL $650 with a coupon
Zepbound® 10 mg / 0.5 mL $650 with a coupon
Zepbound® 12.5 mg / 0.5 mL $650 with a coupon
Zepbound® 15 mg / 0.5 mL $650 with a coupon
Vial
(multi-dose)
Zepbound® 2.5 mg / 0.5 mL vial $349
($299 starting Jan 2026)
Zepbound® 5 mg / 0.5 mL vial $499
($449 starting Jan 2026)
Zepbound® 7.5 mg / 0.5 mL vial $499
($449 starting Jan 2026)
Zepbound® 10 mg / 0.5 mL vial $499
($449 starting Jan 2026)
Zepbound® 12.5 mg / 0.5 mL vial $499
($449 starting Jan 2026)
Zepbound® 15 mg / 0.5 mL vial $499
($449 starting Jan 2026)
All pricing is list pricing based on information provided by the respective drug manufacturers.  End user pricing may vary and for more details, consult with the drug manufacturers directly.

4-6x more weight loss with Zepbound® than diet and exercise alone

In a 72-week controlled trial of adults without diabetes, the percent who saw ≥25% body weight loss (57-58 lbs) on Zepbound®:
  • 5 mg: 15.3%
  • 10 mg: 32.3%
  • 15 mg: 36.2%
  • Placebo: 1.5%
Read more about Zepbound®

Oral Combo Qsymia® Self Pay (phentermine and topiramate)

Phase What It Includes Duration Price Notes
Starter Pack Lowest dose 6 weeks $98 Shipping extra
First Monthly Refill Next dose 30 days $98 Shipping extra
Titration Pack Dose increases up to top dose 6 weeks $98 Shipping extra
All Future Monthly Refills Maintenance dose 30 days $98 Shipping extra
All pricing is list pricing based on information provided by the respective drug manufacturers.  End user pricing may vary and for more details, consult with the drug manufacturers directly. Please note, Qsymia® may not be available in all markets, like via telehealth with knownwell, due to controlled substance designation.

Qsymia® Helped Patients Lose 8–10% of Their Body Weight

In the CONQUER trial (56 weeks), patients randomized to Qsymia® 7.5/46 mg lost an average of ~7.8% of body weight, and those on Qsymia® 15/92 mg lost ~9.8%, compared with ~1.2% for placebo.In the same trial, ~62% of patients on Qsymia® 7.5/46 mg and ~70% on Qsymia® 15/92 mg achieved ≥ 5% weight loss, versus ~21% for placebo.
Read more about Qsymia®

Oral Combo Contrave® Self Pay (naltrexone/bupropion)

Option What It Includes Patient Cost Notes
Cash Pay (No Insurance Coverage) Standard pharmacy fill No more than $1991 Price cap with Contrave® Savings Card
CurAccess™ Program Guaranteed low-cost home delivery $99 or less Includes free shipping; cost depends on insurance coverage
1If you don’t have insurance or if your insurance doesn’t cover Contrave®, you will pay no more than $199.

All pricing is list pricing based on information provided by the respective drug manufacturers.  End user pricing may vary and for more details, consult with the drug manufacturers directly.

Contrave® Helped Patients Lose 2-4x More Weight Compared to Those Who Used Diet and Exercise Alone

Across three clinical studies, adults taking Contrave® alongside diet and exercise lost significantly more weight than those using lifestyle changes alone. In these trials, patients lost:
  • 5.4% (12 lbs) of their starting body weight vs 1.3% 
(3 lbs) with diet and exercise alone (COR-I Study)
  • 8.1% (18 lbs) of their starting body weight vs 4.9% (11 lbs) with diet and exercise alone (COR-BMOD Study)
Read more about Contrave®

Choosing the Right Option With Confidence and Guidance

When choosing a weight-management medication, clinicians look at several key factors:

Looking at Your Overall Health Picture

Conditions like diabetes, cardiovascular disease, high blood pressure, migraines, or mood disorders influence which options are safest, most effective, and least likely to interact with existing health issues or medications.

Thinking About Your Health Goals

Clinicians look at a patient’s target weight-loss percentage. Different treatments produce different average results, so goals such as achieving around 5–10%, 10–15%, or 15%+ total body weight reduction help guide which category of therapy is most appropriate.

Making Sure It Fits Your Budget

Prices vary widely among treatment types, and insurance coverage, cash-pay programs, and manufacturer savings offers can dramatically change out-of-pocket costs. Many patients ultimately choose a medication based on realistic long-term affordability.

Considering How Your Body May React

Each medication category comes with its own pattern of common side effects. Some treatments are more likely to cause gastrointestinal symptoms, while others may lead to things like tingling sensations, dry mouth, changes in mood, sleep disturbances, or blood pressure changes. Matching a patient’s tolerance and sensitivities to the expected side-effect profile is essential.

Finding What Works Best for Your Lifestyle

Some people prefer injectable treatments while others want oral daily medications. Others base their choice on whether they want stronger appetite suppression, more craving control, or a specific dosing schedule. Aligning the treatment to a patient’s lifestyle and comfort level helps support long-term success.
Book Visit Now